Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - STOCK-BASED COMPENSATION
Stock-based Compensation AVXL - Anavex Life Sciences Corp.
9.44 M
LAST VALUE
-28.34%
2 YEAR CAGR
7.97%
5 YEAR CAGR
30.92%
10 YEAR CAGR